Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients


CANDER S., ÖZ GÜL Ö., Dizdar O. S. , Koca N., Aydin T., SARANDÖL E., ...More

METABOLIC SYNDROME AND RELATED DISORDERS, vol.15, no.5, pp.220-225, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.1089/met.2017.0005
  • Journal Name: METABOLIC SYNDROME AND RELATED DISORDERS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.220-225

Abstract

Aim: The mitogenic potential of analog insulins due to their different insulin-like growth factor-1 (IGF1) receptor affinity is a situation that causes concern related to cancer risk. We aimed to examine the changes in the serum IGF1 levels formed by insulin glargine and detemir in the insulin-naive type 2 diabetic patients.